In our in vitro and/or in vivo assays, tumor cell growth and migration were blocked by a TRKB-specific inhibitor in HSC-3 TRKBhigh/BDNFhigh PD-OSCC tumor cells. The gene discussed is NTRK2; the disease is neoplasm.